John Stoltzfus, Oppenheimer chief investment strategist, joins CNBC's 'Squawk on the Street' to discuss how market could ...

Oppenheimer began coverage of Israel-based Camtek (NASDAQ:CAMT) with an Outperform rating and a $100 price target. Shares of ...

A Los Alamos home was featured in one of the biggest summer blockbusters. Now, a group is trying to open it up for the public ...

Filmmaker James Cameron calls "Oppenheimer" a "moral cop-out" for avoiding bombing aftermath scenes, as he develops his own ...

DoorDash (DASH) aims for $4.5B EBITDA by 2027 through ad revenue growth & Deliveroo acquisition. Learn about its flexibility ...

“Yeah…it’s interesting what he stayed away from,” Cameron, 70, told Deadline of Nolan, 54, when asked if he was surprised Oppenheimer won seven Oscars and grossed nearly $1 billion. “Look, I love the ...

Sure, the film echoes actual testimony and captures Oppenheimer ’s inner collapse with chilling precision. But it also leans into spectacle, trimming inconvenient truths and dramatizing quiet tensions ...

Revolution Medicines, Inc. (NASDAQ:RVMD) ranks among the 30 stocks expected to beat the market by 20 percentage points this year.

James Cameron addressed Christopher Nolan's Oppenheimer, saying that the film was a 'moral cop out' due to a lack of certain ...